S2V-74453-06141
4 vaccinations
5 coded responses
33 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 017 / MA
- Registered
- 2021-01-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-30
Dose 1 — Moderna
-
2021-01-31
Registered in v-safe
-
2021-01-31
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-06
-
2021-02-13
Survey response — day 14, dose 1MedDRA: Injection site pain, Injection site pruritus — Feeling: GoodFree text: Return to sourness at injection site, and new itchiness there too. Lasted about 48 hours.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-20
-
2021-02-27
Dose 2 — Moderna
- 2021-02-27
-
2021-02-28
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-01
- 2021-03-02
- 2021-03-03
- 2021-03-04
- 2021-03-05
- 2021-03-06
- 2021-03-13
- 2021-03-20
- 2021-03-27
- 2021-04-03
- 2021-04-10
- 2021-05-29
-
2021-08-28
Survey response — 6 months, dose 2MedDRA: Cough, Fatigue, Oropharyngeal pain, Rhinorrhoea — Feeling: Poor · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Runny nose, sore throat, cough, fatigueMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-28
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-31
-
2021-11-23
Dose 3 — Pfizer-BioNTech
- 2022-02-27
-
2022-11-09
Dose 4 — ModernaCo-administered: Flu
- 2022-11-23
-
2022-11-23
Survey response — 12 months, dose 3MedDRA: Chills, Cough, Fatigue, Pyrexia, Respiratory tract congestion — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Fever, chills, congestion, cough, fatigueMedDRA releases: 2024-11 · check-in free text available
- 2022-11-30
- 2022-12-07
- 2022-12-14
- 2022-12-21
-
2023-02-08
Survey response — 3 months, dose 4MedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend schoolMedDRA releases: 2024-11
-
2023-05-10
Survey response — 6 months, dose 4MedDRA: Respiratory disorder, SARS-CoV-2 test negative — Feeling: Fair · Be unable to work or attend schoolMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-30 | Moderna | |
| 2 | 2021-02-27 | Moderna | |
| 3 | 2021-11-23 | Pfizer-BioNTech | No |
| 4 | 2022-11-09 | Moderna | Flu |
Call center
1 call center case
1 unsuccessful
Free text
Release 4 — day 14, dose 1
Symptoms: Return to sourness at injection site, and new itchiness there too. Lasted about 48 hours.
Release 9 — 6 months, dose 2
Symptoms: Runny nose, sore throat, cough, fatigue
Release 12 — 12 months, dose 3
Symptoms: Fever, chills, congestion, cough, fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Cough | ✓ | · | ✓ |
| SD | Fatigue | ✓ | · | ✓ |
| SD | Injection site pain | ✓ | ✓ | ✓ |
| SD | Injection site pruritus | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | ✓ | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory disorder | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | ✓ | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release